This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Related letter  • Related articles  • Similar articles in JAMA  Topic Collections  • Review  • Alert me on articles by topic  Social Bookmarking   What's this?

Clinical Applications

Eric S. Holmboe, MD

JAMA. 2002;287:373-376.

Oral agents are the mainstay of pharmacologic treatment for type 2 diabetes, and physicians now have a number of agents to choose from. However, more choices translate into more complex decision making. Many patients with diabetes have associated comorbidities, and most diabetic patients will require more than 1 agent to achieve good glycemic control. This article illustrates several of the pharmacologic approaches to type 2 diabetes through 4 situations that use principles of evidence-based medicine. The scenarios also highlight some of the difficulties in choosing the optimal pharmacologic treatment regimen for individual patients. Physicians should also recognize that type 2 diabetes is a multisystem disorder that requires multidisciplinary care, including education and ongoing counseling for effective patient self-management of the disease. Finally, patient preferences are a vital component of informed decision making for pharmacologic treatment of diabetes.

Author Affiliations: Department of Medicine, Yale University School of Medicine, New Haven, Conn, and Qualidigm (Connecticut Peer Review Organization), Middletown, Conn.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Treatment Decisions for Type 2 Diabetes
Mayer B. Davidson and Eric S. Holmboe
JAMA. 2002;287(13):1646-1648.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Oral Antihyperglycemic Therapy for Type 2 Diabetes: Scientific Review
Silvio E. Inzucchi
JAMA. 2002;287(3):360-372.
ABSTRACT | FULL TEXT  

Scientific Review and Clinical Applications
Wendy Levinson and Catherine D. DeAngelis
JAMA. 2002;287(3):379.
EXTRACT | FULL TEXT  

January 16, 2002
JAMA. 2002;287(3):387-388.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Beneath the surface: discovering the unvoiced concerns of older adults with Type 2 diabetes mellitus
Tjia et al.
Health Educ Res 2008;23:40-52.
ABSTRACT | FULL TEXT  

Pharmacy Costs and Glycemic Control in the Department of Veterans Affairs
Weinstock et al.
Diabetes Care 2004;27:B74-B81.
ABSTRACT | FULL TEXT  

Outpatient Insulin Therapy in Type 1 and Type 2 Diabetes Mellitus: Scientific Review
DeWitt and Hirsch
JAMA 2003;289:2254-2264.
ABSTRACT | FULL TEXT  

Using New Insulin Strategies in the Outpatient Treatment of Diabetes: Clinical Applications
DeWitt and Dugdale
JAMA 2003;289:2265-2269.
ABSTRACT | FULL TEXT  

Pharmacological Agents That Directly Modulate Insulin Secretion
Doyle and Egan
Pharmacol. Rev. 2003;55:105-131.
ABSTRACT | FULL TEXT  

Helping Patients Follow Prescribed Treatment: Clinical Applications
Haynes et al.
JAMA 2002;288:2880-2883.
ABSTRACT | FULL TEXT  

Treatment Decisions for Type 2 Diabetes
Davidson and Holmboe
JAMA 2002;287:1646-1648.
FULL TEXT  

Scientific Review and Clinical Applications
Levinson and DeAngelis
JAMA 2002;287:379-379.
FULL TEXT